Veterinary Diagnostics Market: Molecular Testing and AI-Based Diagnostics Create New Growth Opportunities

Veterinary diagnostics plays a crucial role in identifying, monitoring, and preventing diseases in companion animals and livestock through advanced testing technologies, including immunodiagnostics, molecular diagnostics, clinical pathology, and diagnostic imaging.

Veterinary Diagnostics Market: Advancing Animal Healthcare Through Innovation and Early Disease Detection

The global Veterinary Diagnostics Market is witnessing significant growth, driven by increasing pet ownership, rising awareness of animal health, the growing prevalence of zoonotic diseases, and technological advancements in diagnostic solutions. The market was valued at USD 9.72 Billion in 2025 and is projected to reach USD 23.99 Billion by 2034, growing at a CAGR of 10.56% during 2026–2034. Veterinary diagnostics plays a crucial role in identifying, monitoring, and preventing diseases in companion animals and livestock through advanced testing technologies, including immunodiagnostics, molecular diagnostics, clinical pathology, and diagnostic imaging.

* Discover Profitable Growth Opportunities: https://www.maximizemarketresearch.com/request-sample/34589/ 

Veterinary Diagnostics Market Estimation, Growth Drivers, and Opportunities

The increasing demand for preventive veterinary healthcare is one of the major factors supporting market expansion. Growing expenditure on pet healthcare, rising adoption of dogs and cats, and increasing awareness among animal owners regarding early disease detection are encouraging veterinary clinics to adopt advanced diagnostic technologies. Additionally, the increasing prevalence of infectious and zoonotic diseases, including avian influenza and other animal-transmitted infections, is strengthening the demand for reliable diagnostic testing.

The livestock industry also represents a significant growth opportunity as farmers increasingly require effective disease surveillance, food safety monitoring, and animal health management solutions. Technological developments in rapid diagnostic kits, automated laboratory instruments, molecular testing, and artificial intelligence-based diagnostic platforms are improving testing accuracy and reducing turnaround times. Furthermore, the expansion of point-of-care testing creates opportunities for manufacturers to introduce affordable, portable, and user-friendly diagnostic devices, particularly in rural and underserved veterinary markets.

US Veterinary Diagnostics Market: Latest Trends and Investments in 2025

The United States remains a major contributor to the global Veterinary Diagnostics Market, supported by advanced veterinary healthcare infrastructure, high pet ownership, established diagnostic laboratory networks, and continuous investments in animal disease surveillance. In 2025, the market experienced growing interest in early disease detection, molecular testing, and point-of-care diagnostic technologies. IDEXX Laboratories introduced its Cancer Dx screening solution for canine lymphoma in North America, demonstrating the increasing importance of specialized diagnostic testing in companion animal healthcare. Government initiatives also strengthened the country's diagnostic capabilities. The USDA's National Animal Health Laboratory Network (NAHLN) reported substantial diagnostic testing activity during FY2025, including more than 1.1 million PCR tests associated with highly pathogenic avian influenza surveillance and response. Its FY2025 funding allocation reached approximately USD 43.16 million, supporting laboratory infrastructure, disease surveillance, and testing activities. These developments are encouraging investments in advanced laboratory equipment, molecular assays, and rapid animal disease detection technologies.

Veterinary Diagnostics Market Segmentation Analysis

Based on testing type, the Immunoassays (Immunodiagnostics) segment dominated the market in 2025 due to its extensive use in detecting infectious diseases, hormonal conditions, and metabolic disorders. ELISA and lateral-flow testing technologies are widely preferred because they provide rapid, reliable, and cost-effective results. Increasing adoption of automated immunoassay analyzers and multiplex testing solutions is further supporting segment expansion.

Based on end-use, the Laboratories segment held approximately 49% of the global market share in 2025, making it the leading segment. Veterinary laboratories provide essential services for disease surveillance, diagnostic confirmation, research, and quality assurance. Their importance in monitoring transboundary animal diseases and supporting government disease-control programs continues to generate demand.

The market is further segmented by product into consumables, reagents and kits, and instruments and devices. By species, it covers cattle, canine, feline, caprine, equine, ovine, porcine, avian, and others. Disease-based segmentation includes infectious diseases, non-infectious diseases, hereditary, congenital and acquired diseases, general ailments, and structural and functional diseases.

Key Players
North America

  1. IDEXX Laboratories Inc. (USA)
    2. Zoetis Services LLC (USA)
    3. Heska Corporation (USA)
    4. Thermo Fisher Scientific, Inc. (USA)
    5. Antech Diagnostics Inc. (Mars, Inc.) (USA)
    6. VCA Animal Hospitals (Mars, Inc.) (USA)
    7. Neogen Corporation (USA)

Europe
8. bioMérieux SA (France)
9. Virbac Corp (France)
10. Alvedia (France)
11. Randox Laboratories Ltd. (UK)
12. Biopanda Reagents (UK)
13. INDICAL BIOSCIENCE GmbH (Germany)
14. Fassisi GmbH (Germany)
15. QIAGEN N.V. (Germany)
16. Agrolabo S.p.A. (Italy)

Asia-Pacific
17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)
19. BioNote Inc. (South Korea)
20. FUJIFILM Holdings Corporation (Japan)
21. IM3Vet Pty Ltd. (Australia)

Veterinary Diagnostics Market Competitive Analysis

The competitive landscape includes established animal healthcare companies and diagnostic technology providers focusing on product innovation, laboratory expansion, strategic partnerships, and advanced testing capabilities. Five prominent companies identified in the market report include:

  1. IDEXX Laboratories Inc.: A leading veterinary diagnostics company offering laboratory services, diagnostic instruments, and point-of-care testing solutions. Its 2025 Cancer Dx launch for canine lymphoma highlights growing innovation in early cancer detection and specialized veterinary testing.
  2. Zoetis Services LLC: The company provides animal healthcare solutions, including diagnostic-related technologies and animal disease management products. Its continued focus on animal health innovation and infectious disease management supports demand for comprehensive veterinary healthcare solutions.
  3. Heska Corporation: Now part of Mars Petcare, Heska contributes veterinary diagnostic instruments, laboratory solutions, and point-of-care testing technologies. Its integration into Mars' veterinary healthcare ecosystem strengthens access to diagnostic solutions for veterinary practices.
  4. Thermo Fisher Scientific Inc.: The company provides laboratory instruments, molecular testing technologies, reagents, and analytical solutions that support animal disease research and diagnostic testing. Its capabilities in molecular biology and laboratory automation create opportunities for advanced veterinary diagnostics.
  5. Antech Diagnostics Inc. (Mars, Inc.): Antech provides veterinary reference laboratory services and diagnostic solutions. Its laboratory network and integration with Mars' veterinary healthcare businesses support the expansion of diagnostic access and testing capabilities.

Competition is increasingly influenced by rapid testing, improved diagnostic sensitivity, automated laboratory workflows, and digital integration. Companies investing in advanced molecular platforms, oncology testing, and connected diagnostic systems are positioned to benefit from growing demand.

Veterinary Diagnostics Market Regional Analysis

United States: The US is a major national market within North America, supported by advanced veterinary infrastructure, strong companion animal healthcare expenditure, and government-backed animal disease surveillance. USDA-APHIS initiatives and the National Animal Health Laboratory Network strengthen laboratory testing and disease monitoring capabilities.

United Kingdom: The UK market benefits from established veterinary services, animal welfare initiatives, and diagnostic laboratory capabilities. Government disease surveillance and biosecurity measures encourage demand for reliable animal disease testing.

Germany: Germany represents an important European market due to its developed veterinary healthcare infrastructure, livestock industry, and emphasis on animal disease prevention. European animal health regulations and surveillance requirements support the adoption of advanced diagnostic technologies.

France: France benefits from a substantial livestock and companion animal healthcare sector. Veterinary disease monitoring, animal welfare priorities, and European Union animal health requirements contribute to diagnostic market development.

Japan: Japan's advanced healthcare technology ecosystem, growing demand for companion animal healthcare, and emphasis on preventive veterinary services create opportunities for automated and sophisticated diagnostic solutions.

China: China offers considerable growth potential due to its large livestock industry, expanding pet ownership, and increasing focus on food safety and animal disease prevention. Government-supported animal disease monitoring and modernization of veterinary healthcare infrastructure are supporting market development.

Related Reports: 

Niacin and Niacinamide Market https://www.maximizemarketresearch.com/market-report/niacin-and-niacinamide-market/122858/ 
Global Local Anesthesia Drugs Market https://www.maximizemarketresearch.com/market-report/global-local-anesthesia-drugs-market/106101/ 
North America Blood Glucose Monitoring System Market https://www.maximizemarketresearch.com/market-report/blood-glucose-monitoring-system-market-north-america/1638/ 

Conclusion

The Veterinary Diagnostics Market is expected to experience sustained growth as animal healthcare increasingly shifts toward preventive treatment, early disease identification, and technology-enabled diagnostic services. Rising zoonotic disease concerns, growing companion animal populations, livestock disease surveillance, and advancements in molecular and point-of-care testing will remain important growth drivers. In the coming years, companies focusing on affordable rapid diagnostic kits, AI-supported disease detection, automated laboratory instruments, and advanced infectious disease testing are likely to gain significant opportunities. Expanding veterinary diagnostic infrastructure in emerging economies and strengthening public-private partnerships will further support market penetration. Overall, continuous technological innovation and increasing investment in animal healthcare are expected to shape the future development of the global Veterinary Diagnostics Market.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
? +91 9607365656
? sales@maximizemarketresearch.com

 


Aishwarya Bachal

97 Blogg inlägg

Kommentarer